Several large-scale comprehensive analyses, which were conducted using high-throughput sequencing technology, have revealed that the epidermal growth factor receptor (EGFR) signaling pathway and related downstream pathways, such as the PI3K/AKT signaling pathway, are considered to be involved in the development of ESCC [9–11]. The gene discussed is EGFR; the disease is esophageal squamous cell carcinoma.